Table 1.
Well-to-moderately differentiated HCC | Poorly differentiated HCC | P value | |
---|---|---|---|
Method A, reader 1 | |||
D (×10−3 mm2/s) | 1.05 (1.03, 0.72–1.97) | 1.00 (0.95, 0.81–1.37) | 0.3649 |
D* (×10−3 mm2/s) | 551.0 (62.5, 5.0–3553.4) | 303.1 (46.4, 5.0–3410.3) | 0.3990 |
f (%) | 12.7 (11.5, 0–31.1) | 12.8 (11.3, 5.9–22.1) | 0.6864 |
reader 2 | |||
D (×10−3 mm2/s) | 1.04 (1.04, 0.58–1.97) | 0.97 (0.92, 0.76–1.34) | 0.2399 |
D* (×10−3 mm2/s) | 538.6 (44.6, 5.0–4181.4) | 325.0 (47.2, 5.3–3522.7) | 0.7672 |
f (%) | 12.8 (13.2, 0–32.3) | 12.9 (12.5, 5.0–24.7) | 0.9072 |
Method B, reader 1 | |||
D (×10−3 mm2/s) | 0.95 (0.96, 0.70–1.28) | 0.72 (0.71, 0.55–0.97) | <0.0001† |
D* (×10−3 mm2/s) | 228.5 (30.7, 5.0–3904.2) | 19.0 (15.7, 5.0–77.9) | 0.0211† |
f (%) | 16.5 (15.8, 0–53.8) | 23.6 (23.4, 8.9–50.2) | 0.0232† |
reader 2 | |||
D (×10−3 mm2/s) | 0.95 (0.97, 0.65–1.34) | 0.75 (0.76, 0.54–0.97) | 0.0005† |
D* (×10−3 mm2/s) | 323.2 (31.4, 5.0–2642.7) | 22.6 (13.9, 5.1–78.5) | 0.0366† |
f (%) | 15.7 (15.9, 0–53.3) | 21.7 (18.7, 8.2–50.7) | 0.0834 |
Method C, reader 1 | |||
D (×10−3 mm2/s) | 0.95 (0.96, 0.70–1.28) | 0.72 (0.71, 0.55–0.97) | <0.0001† |
D* (×10−3 mm2/s) | 204.6 (15.8, 0–2214.1) | 7.88 (6.47, 5.0–12.3) | 0.0004† |
f (%) | 18.3 (17.9, 0–55.7) | 29.2 (31.6, 9.7–54.3) | 0.0016†† |
reader 2 | |||
D (×10−3 mm2/s) | 0.95 (0.97, 0.65–1.34) | 0.75 (0.76, 0.54–0.97) | 0.0005† |
D* (×10−3 mm2/s) | 155.1 (14.1, 0–2292.9) | 8.71 (7.96, 5.0–14.6) | 0.0192† |
f (%) | 17.8 (16.7, 0–55.7) | 25.9 (24.6, 11.5–54.5) | 0.0279†† |
Statistical analyses were performed using the Wilcoxon test. Data are presented as the mean (median, range). HCC, hepatocellular carcinoma; D, true diffusion coefficient; D*, diffusion coefficient for perfusion; f, perfusion fraction.
, The D and D* values of poorly differentiated HCCs were lower than were those of well-to-moderately differentiated HCCs (P < 0.05);
, The f value of poorly differentiated HCCs was higher than was that of well-to-moderately differentiated HCCs (P < 0.05).